Learn more about Genomic Health's diagnostic tests, for breast and colon cancer, which can help patients and their doctors make better, more informed treament decisions.
Oncotype DX breast cancer test validated to predict local recurrence in patients with ductal carcinoma in situ DCIS, or pre-invasive breast cancer. Read more...
See how we are turning the promise of genomics into the practice of medicine. Includes a step-by-step "demo" of the Oncotype DX test process.
View a recent Bloomberg interview with CEO Kim Popovits and learn more about Genomic Health's perspective on genomics in cancer and current business highlights.
Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology 2012 Annual Meeting
Genomic Health to Present at the JMP Securities Research Conference
